Brexit – UK clinicians Warn of No-Deal Consequences for Patients

In an open letter published in The Lancet, Marc Tischkowitz, Beverley Power, Graham Slater and 70 additional cosignatories have highlighted the detrimental health implications of a “no deal” Brexit for the 1 in 17 UK citizens who are diagnosed with a rare disease.

A “no deal” will result in the exclusion of the UK from the 24 ERNs that were established to improve the care of the patients bearing the lifelong burden of these conditions, which require highly specialised diagnosis and treatment.